Lymphoma Research Foundation Press Room:

3/27/09 - FDA Approves New Treatment for CTCL
The U.S. Food and Drug Administration (FDA) approved THERAKOS CELLEX Photopheresis System.

3/25/09 - New Drug Application Submitted to FDA
Allos Therapeutics, Inc. submits New Drug Application for the treatment of relapsed or refractory peripheral T-cell lymphoma.

3/9/09 - Research study for bone marrow/stem cell transplant survivors
Study Opens

2/27/09 - Cancer Prevention Report Urges Action

2/12/09 - Prelixafor Approved by FDA
(Mobozil) receives approval for patients with non-Hodgkin lymphoma undergoing autologous stem cell transplant.

2/4/09 - Final Phase 2 Results of Treatment for Relapsed Peripheral T-cell lymphoma (PTCL)
Allos Therapeutics' pralatrexate shows 27% response rate and median duration that exceeds nine months

2/3/09 - Two Lymphoma Drugs Reach the FDA
CLL drug ofatumumab and aggressive non-Hodgkin lymphoma drug pixantrone submitted to FDA for Biologics License Application and New Drug Application.

1/28/09 - New Monoclonal Antibody Granted “Orphan Drug” Status from FDA
Anti-CD30 monoclonal antibody for anaplastic large cell lymphoma and Hodgkin lymphoma

1/23/09 - Reduced-Intensity Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL)
Possibility of cure improved in patients, many of which have previously failed prior autologous procedure.

1/13/09 - Improved CLL Therapy: Less Toxic, More Effective
Investigators recalibrate FCR drug regimen to improve patient outcomes.

12/30/08 - Lymphoma and the FDA: Year in Review
2008 a banner year for lymphoma drug approvals and orphan drug designations.

12/30/08 - Coping with Lymphoma During the Holidays
Coping with lymphoma during the holiday season can be challenging. Some helpful tips may make it easier for you this time of year.

12/19/08 - Disrupting the Cancer Assembly Line
Dr. Kapil Bhalla, Medical College of Georgia, aims to exploit a weakness of cancer cells

12/22/08 - Varmus Named Obama’s Pick
President-elect chooses Council of Advisors on Science and Technology chair

12/7/08 - LRF-Funded Vaccine and Novel Drug Trials at ASH

12/6/08 - Results Presented From Two Exciting Novel Drug Clinical Trials
Scientific Advisory Board member and LRF grant recipient, Owen O’Connor, MD, PhD introduced new data on from two new exciting novel drug clinical trials.

12/5/08 - Scientists from Around the World Convene to Discuss Lymphoma
LRF is proud of its many grant recipients highlighted this year at ASH

12/5/08 - American Society of Hematology Marks Its 50th Anniversary

12/3/08 - Highlights from the 2008 American Society of Hematology (ASH) Annual Meeting & Exposition
Blood Cancer Experts Share Discoveries

12/4/08 - Treatment Response Correlates with Gene Expression
A gene-based study can predict how patients with large-B-cell lymphoma will respond to treatment.